The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2023 | The IMWG frailty score explained
Michel Delforge, MD, PhD, University of Leuven, Leuven, Belgium, explains the International Myeloma Working Group (IMWG) frailty score, a system that allows stratifying patients with myeloma into different categories based on age, comorbidities, Activities of Daily Living (ADL), and Instrumental Activities of Daily Living (IADL). Prof. Delforge discusses why this system was created, what drawbacks arise, and how newer scoring systems have been created based on this initial framework. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consulting or Advisory Role – Amgen (Inst); Bristol Myers Squibb Foundation (Inst); GlaxoSmithKline (Inst); Janssen Research & Development (Inst); Sanofi (Inst); Stemline Therapeutics (Inst); Takeda (Inst)
Research Funding – Janssen Research & Development (Inst)
